Status:

UNKNOWN

Complications Related to Transpulmonary Thermodilution

Lead Sponsor:

Bicetre Hospital

Conditions:

Critical Illness

Hemodynamic Instability

Eligibility:

All Genders

18+ years

Brief Summary

The transpulmonary thermodilution is commonly used in patients with acute circulatory failure in the intensive care unit and for monitoring surgical patients at high risk. However, the incidence of co...

Detailed Description

Transpulmonary thermodilution (TPTD) is a technique used for haemodynamic monitoring. It consists of a monitor device which is connected to two catheters. One is a catheter inserted into the superior ...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Monitoring by a TPTD system (PiCCO2 or VolumeView/EV1000) already planned or set up

Exclusion

  • None

Key Trial Info

Start Date :

February 8 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2023

Estimated Enrollment :

2000 Patients enrolled

Trial Details

Trial ID

NCT04319965

Start Date

February 8 2020

End Date

June 30 2023

Last Update

May 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bicetre Hospital

Paris, Val-de-Marne, France, 94270